Results
1 -
6 of
6Ma Xiao-Dong, Qiu Ni, Yang Bo, He Qiao-Jun, Hu Yong-Zhou.
Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation, Med. Chem. Commun., 2016 eIF4E Phosphorylation Downstream of MAPK Pathway, Translation and Its Regulation in Cancer Biology and Medicine A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer, Targeted Oncology First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors, Investigational New Drugs Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC), Cancers of the Head & Neck